RHONDA HETTINGER: Open Payments
NPI 1407844996 · CLARKSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,498 in 131 payments from 29 companies in 2025. Trend: 2023 $5,448 · 2024 $6,553 · 2025 $2,498
Food & beverage: $2,491Education: $7
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $585 |
| Regeneron Healthcare Solutions, Inc. | 7 | $231 |
| ABBVIE INC. | 12 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $202 |
| Currax Pharmaceuticals LLC | 21 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $136 |
| Novo Nordisk Inc | 6 | $112 |
| Esperion Therapeutics, Inc. | 6 | $111 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Amgen Inc. | 5 | $84 |
Products named: FARXIGA, EVKEEZA, BREZTRI, Kerendia, CONTRAVE, TRINTELLIX, VRAYLAR, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
